Rahmi Lale is an academic at the Department of Biotechnology and Food Science at the Norwegian University of Science and Technology (NTNU) in Trondheim, Norway. He is also the co-founder and CEO of Syngens, an NTNU spin-off operating at the intersection of Artificial Intelligence (AI) and Synthetic Biology.

At NTNU, he leads an interdisciplinary lab that integrates biophysics, computational, and synthetic biology. His primary research focus is on understanding and controlling transcriptional and translational regulation in various microorganisms, ranging from bacteria to higher eukaryotes.

At Syngens, he leverages the predictive power of AI to engineer biological systems for biomanufacturing applications.